Bank of New York Mellon’s Twist Bioscience TWST Stock Holding History

Bank of New York Mellon’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.7M	Buy	191,698 +10,881	+6%	+$708K	﹤0.01%	1632
2026 Q1	$8.59M	Sell	180,817 -2,124	-1%	-$95.2K	﹤0.01%	2017
2025 Q4	$5.8M	Sell	182,941 -315,320	-63%	-$9.84M	﹤0.01%	2235
2025 Q3	$14M	Sell	498,261 -29,875	-6%	-$905K	﹤0.01%	1746
2025 Q2	$19.4M	Sell	528,136 -13,061	-2%	-$451K	﹤0.01%	1537
2025 Q1	$21.2M	Sell	541,197 -38,379	-7%	-$1.73M	﹤0.01%	1471
2024 Q4	$26.9M	Sell	579,576 -35,373	-6%	-$1.6M	0.01%	1387
2024 Q3	$27.8M	Sell	614,949 -74,082	-11%	-$3.52M	0.01%	1390
2024 Q2	$34M	Sell	689,031 -466,419	-40%	-$19M	0.01%	1256
2024 Q1	$39.6M	Sell	1,155,450 -264,079	-19%	-$9.53M	0.01%	1175
2023 Q4	$52.3M	Buy	1,419,529 +217,420	+18%	+$5.03M	0.01%	1014
2023 Q3	$24.4M	Sell	1,202,109 -55,896	-4%	-$1.23M	0.01%	1449
2023 Q2	$25.7M	Buy	1,258,005 +469,159	+59%	+$7.03M	0.01%	1411
2023 Q1	$11.9M	Sell	788,846 -10,423	-1%	-$230K	﹤0.01%	1835
2022 Q4	$19M	Sell	799,269 -21,980	-3%	-$637K	﹤0.01%	1564
2022 Q3	$28.9M	Buy	821,249 +19,979	+2%	+$848K	0.01%	1268
2022 Q2	$28M	Sell	801,270 -46,362	-5%	-$1.64M	0.01%	1339
2022 Q1	$41.9M	Buy	847,632 +186,115	+28%	+$10.3M	0.01%	1214
2021 Q4	$51.2M	Sell	661,517 -16,874	-2%	-$1.73M	0.01%	1143
2021 Q3	$72.6M	Buy	678,391 +10,375	+2%	+$1.19M	0.01%	867
2021 Q2	$89M	Sell	668,016 -100,293	-13%	-$11.7M	0.02%	769
2021 Q1	$95.2M	Sell	768,309 -176,533	-19%	-$26.8M	0.02%	725
2020 Q4	$133M	Sell	944,842 -88,667	-9%	-$9.84M	0.03%	524
2020 Q3	$78.5M	Buy	1,033,509 +53,233	+5%	+$3.31M	0.02%	680
2020 Q2	$44.4M	Buy	980,276 +60,132	+7%	+$2.16M	0.01%	952
2020 Q1	$28.1M	Buy	920,144 +842,556	+1,086%	+$22.7M	0.01%	1079
2019 Q4	$1.63M	Buy	77,588 +3,054	+4%	+$71.5K	﹤0.01%	2947
2019 Q3	$1.78M	Buy	74,534 +5,841	+9%	+$170K	﹤0.01%	2810
2019 Q2	$1.99M	Buy	68,693 +49,762	+263%	+$1.32M	﹤0.01%	2800
2019 Q1	$439K	Buy	+18,931	New	+$428K	﹤0.01%	3609

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Bank of New York Mellon's TWST Position: Q2 2026 in Review

Bank of New York Mellon increased its Twist Bioscience (TWST) stake by 6% in Q2 2026, buying an estimated $708K and bringing the position to 191,698 shares worth $19.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

Bank of New York Mellon first reported a position in TWST in Q1 2019 and has held it in 30 quarters since. The position peaked at $133M in Q4 2020. 130 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Bank of New York Mellon held 191,698 shares of Twist Bioscience worth $19.7M as of Q2 2026.
Bank of New York Mellon bought 10,881 Twist Bioscience shares in Q2 2026, an estimated $708K.
Twist Bioscience made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1632 holding.
Bank of New York Mellon first reported a position in Twist Bioscience in Q1 2019 and has held it in 30 quarters since.
Bank of New York Mellon's Twist Bioscience position peaked at $133M in Q4 2020.
130 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.